CStone Pharmaceuticals Stock Deutsche Boerse AG
Stocks
PH4
KYG2588M1006
Pharmaceuticals
OTC Markets Traded|
Market Closed -
Deutsche Boerse AG
16:25:02 14/08/2026 +03
|
5-day change | 1st Jan Change | ||
| 0.6174 EUR | -0.39% |
|
+9.98% | +8.32% |
| Market Cap | 7.89B 1.17B 1.01B 950M 864M 1.62B 112B 1.65B 11.13B 4.35B 56.03B 4.39B 4.3B 186B | P/E 2026 * |
-370x | P/E 2027 * | 7.37x |
|---|---|---|---|---|---|
| Enterprise Value | 7.36B 1.09B 943M 886M 806M 1.52B 104B 1.54B 10.38B 4.06B 52.28B 4.1B 4.01B 174B | EV / Sales 2026 * |
15.4x | EV / Sales 2027 * | 2.5x |
| Free-Float |
80.15% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: CStone Pharmaceuticals
| 1 day | -0.39% | ||
| 1 week | +9.98% | ||
| Current month | +32.06% | ||
| 1 month | +16.80% | ||
| 3 months | -29.81% | ||
| 6 months | -0.42% | ||
| Current year | +8.32% |
| 1 week | 0.57 |  | 0.64 |
| 1 month | 0.45 | | 0.64 |
| Current year | 0.45 | | 1.12 |
| 1 year | 0.45 | | 1.35 |
| 3 years | 0.09 | | 1.35 |
| 5 years | 0.09 | | 1.55 |
| 10 years | 0.09 | | 1.98 |
| Manager | Title | Age | Since |
|---|---|---|---|
Jian Xin Yang
CEO | Chief Executive Officer | 62 | 25/08/2022 |
Wei Cong Ni
DFI | Director of Finance/CFO | - | 18/01/2023 |
Ying Hua Zhang
COO | Chief Operating Officer | 46 | 01/08/2016 |
| Director | Title | Age | Since |
|---|---|---|---|
Wei Li
CHM | Chairman | 55 | - |
Jian Xin Yang
BRD | Director/Board Member | 62 | 25/08/2022 |
Edward Hu
BRD | Director/Board Member | 63 | 09/07/2021 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.39% | +9.98% | - | - | 1.18B | |
| -0.31% | +2.44% | +41.97% | -0.61% | 80.48B | |
| -1.02% | -0.51% | -2.54% | +26.80% | 51.06B | |
| -3.10% | -4.84% | +9.26% | +158.46% | 48.19B | |
| -0.74% | +3.26% | -49.46% | -48.10% | 46.5B | |
| -0.39% | +0.91% | +55.50% | -23.07% | 31.12B | |
| -0.52% | +7.01% | +137.24% | -36.68% | 25.41B | |
| -0.30% | -0.33% | +39.46% | +84.18% | 24.43B | |
| -1.42% | -1.11% | -2.29% | +189.51% | 21.11B | |
| -1.83% | -2.82% | +61.91% | +105.60% | 16.28B | |
| Average | -1.00% | +1.44% | +32.34% | +50.68% | 38.29B | |
| Weighted average by Cap. | -1.02% | +1.11% | +24.76% | +37.28% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 479M 71.07M 61.38M 57.68M 52.46M 98.62M 6.8B 100M 676M 264M 3.4B 267M 261M 11.31B | 1.71B 254M 219M 206M 188M 353M 24.29B 358M 2.42B 945M 12.16B 954M 933M 40.42B |
| Net income | -243M -36.06M -31.14M -29.27M -26.62M -50.04M -3.45B -50.86M -343M -134M -1.73B -135M -132M -5.74B | 687M 102M 88.03M 82.72M 75.23M 141M 9.75B 144M 969M 379M 4.88B 383M 374M 16.22B |
| Net Debt | -528M -78.31M -67.64M -63.56M -57.81M -109M -7.49B -110M -745M -291M -3.75B -294M -288M -12.46B | -3.6B -534M -461M -434M -394M -741M -51.08B -754M -5.08B -1.99B -25.58B -2.01B -1.96B -85.01B |
| Date | Price | Change |
|---|---|---|
| 14/08/26 | €0.6174 | -0.39% |
| 13/08/26 | €0.6198 | -0.16% |
| 12/08/26 | €0.6208 | -2.60% |
| 11/08/26 | €0.6374 | +12.50% |
| 10/08/26 | €0.5666 | +0.93% |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- 2616 Stock
- PH4 Stock
Select your edition
All financial news and data tailored to specific country editions
